Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Cancer Research|December 24, 2009
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growthNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
BMC Medical Genetics|September 19, 2012
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomasNimrod B Kiss, Per Kogner, John Inge Johnsen, et al.
International Journal of Oncology|February 13, 2003
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrateIrina Svechnikova, Steven G Gray, Jurgita Kundrotiene, et al.
BMC Medical Genomics|August 19, 2009
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genesKaisa Thorell, Annika Bergman, Helena Carén, et al.
International Journal of Cancer|July 1, 2011
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivoLova Segerström, Ninib Baryawno, Baldur Sveinbjörnsson, et al.
BMC Genomics|September 9, 2011
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumorsHanna Kryh, Helena Carén, Jennie Erichsen, et al.
International Journal of Oncology|July 14, 2011
MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastomaHanna Kryh, Jonas Abrahamsson, Elsa Jegerås, et al.
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
International Journal of Oncology|February 23, 2008
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesisCecilia Krona, Helena Carén, Rose-Marie Sjöberg, et al.
Oncoimmunology|June 27, 2013
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytesLena-Maria Carlson, Anna De Geer, Baldur Sveinbjørnsson, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Cancer Research|December 24, 2009
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growthNinib Baryawno, Baldur Sveinbjörnsson, Staffan Eksborg, et al.
BMC Medical Genetics|September 19, 2012
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomasNimrod B Kiss, Per Kogner, John Inge Johnsen, et al.
International Journal of Oncology|February 13, 2003
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrateIrina Svechnikova, Steven G Gray, Jurgita Kundrotiene, et al.
BMC Medical Genomics|August 19, 2009
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genesKaisa Thorell, Annika Bergman, Helena Carén, et al.
International Journal of Cancer|July 1, 2011
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivoLova Segerström, Ninib Baryawno, Baldur Sveinbjörnsson, et al.
BMC Genomics|September 9, 2011
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumorsHanna Kryh, Helena Carén, Jennie Erichsen, et al.
International Journal of Oncology|July 14, 2011
MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastomaHanna Kryh, Jonas Abrahamsson, Elsa Jegerås, et al.
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
International Journal of Oncology|February 23, 2008
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesisCecilia Krona, Helena Carén, Rose-Marie Sjöberg, et al.
Oncoimmunology|June 27, 2013
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytesLena-Maria Carlson, Anna De Geer, Baldur Sveinbjørnsson, et al.
Pageof 17